Use of antiepileptic drugs and risk of fractures: Case-control study among patients with epilepsy

Neurology

Volumn 66, Issue 9, 2006, Pages 1318-1324

  Souverein, P C ^a   Webb, D J ^b   Weil, J G ^b   Van Staa, T P ^a,c,d   Egberts, A C G ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYTOCHROME P450; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; AGED; ARTICLE; BONE METABOLISM; CASE CONTROL STUDY; CONTROLLED STUDY; EPILEPSY; FALLING; FEMALE; FRACTURE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK;

ACCIDENTAL FALLS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BENZODIAZEPINES; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; CONFOUNDING FACTORS (EPIDEMIOLOGY); CYTOCHROME P-450 ENZYME SYSTEM; DATABASES, FACTUAL; DISEASE SUSCEPTIBILITY; DRUG UTILIZATION; ENGLAND; ENZYME INDUCTION; EPILEPSY; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK; SEVERITY OF ILLNESS INDEX; SEX FACTORS; WALES;

EID: 33646671744     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000210503.89488.88     Document Type: Article

References (19)

1. Souverein PC, Webb DJ, Petri H, Weil J, Van Staa TP, Egberts ACG. Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia 2005;46:304-310.
2. Vestergaard P. Epilepsy, osteoporosis and fracture risk: a meta analysis. Acta Neurol Scand 2005;112:277-286.
3. Mattson RH, Gidal BE. Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav 2004;5 (suppl 2):S36-S40.
4. Pack A. The association between antiepileptic drugs and bone disease. Epilepsy Currents 2003;3:91-95.
5. Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs 2001;15:633-642.
6. Persson HB, Alberts KA, Farahmand BY, Tomson T. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia 2002;43:768-772.
7. Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999;99:269-275.
8. Ali II, Schuh L, Barkley GL, Gates JR. Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav 2004;5:296-300.
9. Sheth RD. Bone health in epilepsy. Lancet Neurol 2004;3:516.
10. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350:1097-1099.
11. Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HGM. The use of a large pharmacoepidemiologic database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Safety 2000;9:359-366.
12. Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 2003;4:169-174.
13. Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL. Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 2004;62:2051-2057.
14. Petty SJ, Paton LM, O'Brien TJ, et al. Effect of antiepileptic medication on bone mineral measures. Neurology 2005;65:1358-1363.
15. Lawn ND, Bamlet WR, Radhakrishnan K, O'Brien PC, So EL. Injuries due to seizures in persons with epilepsy: a population-based study. Neurology 2004;63:1565-1570.
16. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004;45:1330-1337.
17. Stephen LJ, McLellan AR, Harrison JH, et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 1999;8:339-342.
18. Boluk A, Guzelipek M, Savli H, Temel I, Ozisik HI, Kaygusuz A. The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res 2004;50:93-97.
19. Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001;57:445-449.